Select Page

The Newsroom

A collection of stories and updates that can be seen & heard on social media and in the press

Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System and NPS PLUS
Silk Road Medical, Inc. today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.
Silk Road Medical Names Chas McKhann Chief Executive Officer
Silk Road Medical Receives 2023 Great Place To Work Certification™
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting
Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region
TCAR Associated with an Improvement in Overall Outcomes for Carotid Revascularization
Silk Road Medical Names Rick Anderson to Board of Directors
Silk Road Medical Strengthens Leadership Team
Compelling Outcomes with TCAR vs. CEA in Patients with Carotid Artery Stenosis Published in the Annals of Surgery
ROADSTER 2 Data Publication in Stroke Demonstrates Compelling Patient Outcomes and Strong Safety Profile with TCAR
Silk Road Medical Promotes Andrew Davis to Newly Created Position of Chief Commercial Officer
Society for Vascular Surgery (SVS) Issues Guidance on Competence Recommendations for TCAR
For a complete list of press releases, please click here: